← New search
Gene profile

VKORC1

HGNC:23663 · SaudiVarKB evidence summary derived from retained literature mentions.

15Gene mentions
15Publications
18Linked variants
5Associated phenotypes

Associated phenotypes

Co-mentioned in VKORC1 publications
PhenotypeIdentifierArticlesMentions
diabetes mellitus11
sickle cell diseaseHP:000187811
familial hypercholesterolemiaHP:000312411
renal failure11
stroke11

Linked variants

Variants normalized to VKORC1
VariantHGVS / rsIDArticlesMentions
rs9923231rs992323122
-1173C>T22
p.Asp36Tyrp.Asp36Tyr11
rs61742245rs6174224511
rs98332238rs9833223811
rs9332172rs933217211
rs1057910rs105791011
rs9332230rs933223011
rs1799853rs179985311
rs1057911rs105791111
rs9332119rs933211911
rs28399511rs2839951111
rs3758581rs375858111
rs11572080rs1157208011
rs10509681rs1050968111
rs9934438rs993443811
rs7294rs729411
C1173T11

Population context

Reported in the same publications
Country / regionGroupCohortArticles
Saudi Arabia4
Not specified01
Saudi Arabia1001
Saudi Arabia221
Not specified2,0001
Not specified1071
Saudi Arabia · Central Province1111
Saudi Arabia1931
Not specified541
Saudi Arabia7861
Saudi Arabia9361

Supporting publications

15 records
  1. 2026Clinical Pharmacogenomic Variants Among the Saudi Population and Their Impact on Drug Response: A Review of Saudi-Based Evidence.CureusPubMed ↗
  2. 2025The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients.Frontiers in pharmacologyPubMed ↗
  3. 2025The Genetic Polymorphisms of CYP2C9 and VKORC1 in the Saudi Population and Their Impact on Anticoagulant Management.Medicina (Kaunas, Lithuania)PubMed ↗
  4. 2023Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).The pharmacogenomics journalPubMed ↗
  5. 2023The Association Between Bone Remodeling Markers, genes polymorphisms with Incidence of Osteopenia Among Young Saudi Female.Cellular and molecular biology (Noisy-le-Grand, France)PubMed ↗
  6. 2022Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.PloS onePubMed ↗
  7. 2022Association of VKORC1 and CYP2C9 single-nucleotide polymorphisms with warfarin dose adjustment in Saudi patients.Drug metabolism and personalized therapyPubMed ↗
  8. 2022Determination of Pleiotropic Effect of Warfarin in VKORC1 and CYP2C9 Genotypes in Patients With Heart Valve Replacement.Frontiers in cardiovascular medicinePubMed ↗
  9. 2022Association of VKORC1 and CYP2C9 single-nucleotide polymorphisms with warfarin dose adjustment in Saudi patients.Drug metabolism and personalized therapyPubMed ↗
  10. 2021Pharmacogenetic determinants of warfarin in the Indian population.Pharmacological reports : PRPubMed ↗
  11. 2020The effect of the VKORC1 promoter variant on warfarin responsiveness in the Saudi WArfarin Pharmacogenetic (SWAP) cohort.Scientific reportsPubMed ↗
  12. 2019Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.Clinical pharmacology and therapeuticsPubMed ↗
  13. 2018Utilizing Whole-Exome Sequencing to Characterize the Phenotypic Variability of Sickle Cell Disease.Genetic testing and molecular biomarkersPubMed ↗
  14. 2016A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.PloS onePubMed ↗
  15. 2016VKORC1 gene (vitamin K epoxide reductase) polymorphisms are associated with cardiovascular disease in chronic kidney disease patients on hemodialysis.Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi ArabiaPubMed ↗